Legal Framework: Counterfeit Medicines.
|
|
- Hollie Hopkins
- 5 years ago
- Views:
Transcription
1 Legal Framework: Counterfeit Medicines. AIFA and the actions against drugs counterfeiting Marcello Chiavoni Zagreb, November 2014
2 Public Declaration of transparency/interests* The view and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to AIFA Direct interests: Interests in pharmaceutical industry NO Currently Last 2 years More than 2 years but less than 5 years ago More than 5 years ago (optional) Employment with a company Consultancy for a company Strategic advisory role for a company Financial interests Ownership of a patent X X X X X Indirect interests: Principal investigator Investigator Individual s Institution/Organisation receives a grant or other funding X X X *Marcello Chiavoni, in accordance with the Conflict of Interest Regulations approved by AIFA Board of Directors ( ) and published on the Official Journal of according to 0044 EMA/513078/2010 on the handling of the conflicts of interest for scientific committee members and experts N.B. < I am not receiving any compensation>
3 PHENOMENON The problem of falsified and illegal medicines has registred in the last years a growing trend, which is partially traceable back to the explosion of illegal e- pharmacies on the Internet. The worldwide dimensions phenomenon were demonstrated by many recent cases.
4 FALSIFIED MEDICINES Any medicinal product with a false representation of: (a) its identity, including its packaging and labelling, its name or its composition as regards any of the ingredients including excipients and the strength of those ingredients; (b) its source, including its manufacturer, its country of manufacturing, its country of origin or its marketing authorisation holder; or (c) its history, including the records and documents relating to the distribution channels used. [Directive 2011/62/EU]
5 FEATURES Absence of active ingredient Different active ingredients and different dosage from what in the label Dangerous or contaminated ingredients These different types of products have in common the low quality; we cannot establish who s the manufacturer, with what kind of ingredients and manufacturing processes they were made.
6 THE PHENOMENON IN ITALY In Italy the incidence of the problem is lower, in comparison with other UE Member States or third countries, due to the preventive and counteracting initiatives such as the track and trace system in use for the medicines, to the authorisation and monitoring processes in use for imported medicines and, moreover, to the collaboration among many institutions and to the control of police forces in the field.
7 THE PHENOMENON IN ITALY As far as legal medicines are concerned, such as the ones dispensed by health care facilities or purchased in pharmacies and parapharmacies, the distribution network is safe. In recent years we never registered cases of illegal and/or counterfeit products in the legal chains. The danger is represented by the illegal distribution channels, such as the online pharmacies.
8 IMPACT ITALIA Italian Medicines Agency AIFA Police Carabinieri NAS OMCL ISS Ministry of Health Customs Agency Anti-Fraud Ministry of Economic Development USMAF Industries Pharmacies Health prof. Patients
9 LEGAL CONSUMPTIONS Products for erectile disfunctions (Cialis, Viagra, Levitra) Sold packages (2009) Sold packages (2010) Sold packages (2011)
10 LEGAL CONSUMPTIONS MEDICINES FOR CENTRAL NERVOUS SYSTEM % (spending) % (consumptions) ANTIDEPRESSANTS % (yearly variation) The first three medicines prescribed (per amount): Paroxetin Escitalopram Sertralin Among the prescribed active ingredients (not reimbursed), benzodiazepines are at the first place for spending and consumption (17.2% of the total amount of not reimbursed medicines).
11 INTERNET ILLEGAL OFFER The web monitoring project promoted by AIFA (August 2011) shows that the active ingredients most frequently offered on the Internet are: Gabapentin Serotonin Escitalopram Citalopram Sertralin
12 COUNTERACTING ACTIVITIES Regulation Enforcement Training COMMUNICATION
13 REGULATION Directive 2011/62/EU Enforces preventive and counteracting activities for the protection of the legal distribution/manufacturing sector. MediCrime Convention (CoE) The first binding criminal law international instrument on counterfeiting of medical products and similar crimes involving threats to public health.
14 ENFORCEMENT PANGEA IV seized units (counterfeit/illegal medicines) PANGEA V seized units (counterfeit/illegal medicines) DIETARY SUPPLEMENTS 2012 Medicines sold as dietary supplements or natural products in in non pharmaceutical shops E-PHARMACIES 100 illegal websites shut down through 3 operative procedures
15 TRAINING 43 countries (CoE); 200 officials trained in ad hoc courses (CoE); 8 publications; 500 Italian officers involved (health authorities, police, customs).
16 E-PHARMACIES Starting from the assessment of illegality, based on the current regulations (D.lgs 219/2006, Consumer Code or other laws regulating the advertising in the pharmaceutical sector), it is possibile to act against illegal website, by targeting: Registrants Hosts Ise Providers Webmasters
17 ENFORCEMENT IN ITALY Counterfeiting prevention task-force (Art. 142 bis) Intersectoral cooperation between health authorities (AIFA; MoH), Customs, Police (Art. 142 quater) Conference of Stakeholders on illegal e-pharmacies (Art. 142 quinquies)
18 INTERNATIONAL PUBLICATIONS
19 CONTACTS Marcello Chiavoni Pharmacist Anti-Counterfeiting Unit, AIFA
Council of Europe The Medicrime Convention. Combating counterfeiting of medical products and similar crimes
Council of Europe The Medicrime Convention Combating counterfeiting of medical products and similar crimes Counterfeiting of medical products and similar crimes involving threats to public health are a
More informationCounterfeit Medicinal Products. FINLAND Roschier, Attorneys Ltd.
Counterfeit Medicinal Products FINLAND Roschier, Attorneys Ltd. CONTACT INFORMATION Mikael Segercrantz Robert Hagelstam Roschier, Attorneys Ltd. Keskuskatu 7 A 00100 Helsinki, Finland 358.20.506.6000 mikael.segercrantz@roschier.com
More informationCouncil of Europe The Medicrime Convention
Council of Europe The Medicrime Convention Combating counterfeiting of medical products and similar crimes What is a counterfeit medical product? It is a product with a deliberately false representation
More informationCounterfeit Medicinal Products. POLAND Wardyński & Partners
Counterfeit Medicinal Products POLAND Wardyński & Partners CONTACT INFORMATION Ewa Butkiewicz, Ph.D. Wardyński & Partners Al. Ujazdowskie 10 00-478 Warsaw, Poland 48.22.437.82.00 ewa.butkiewicz@wardynski.com.pl
More informationTHE MEDICRIME CONVENTION
Council of Europe THE MEDICRIME CONVENTION Fighting the falsification of medical products and similar crimes The MEDICRIME Convention in a few words Crime linked to the manufacture, distribution and sale
More informationTHE MEDICRIME CONVENTION
Council of Europe THE MEDICRIME CONVENTION Fighting the falsification of medical products and similar crimes The Medicrime Convention in a few words Crime linked to the manufacture, distribution and sale
More informationMeasuring Illicit Tobacco Markets
3rd International Conference on Governance, Crime and Justice Statistics UNODC- INEGI Merida (Mexico) 7-10 June 2016 Measuring Illicit Tobacco Markets Ernesto U. Savona Director and Professor (ernesto.savona@unicatt.it)
More informationFrance: Millions of medicines seized in largest INTERPOL operation against illicit online pharmacies
LYON, France, September 25 (Infosplusgabon) - In the largest action of its kind, INTERPOL s Operation Pangea X, targeting the illicit online sale of medicines and medical devices, has resulted in some
More informationUse of quantitative tools for study planning purposes and study design optimisation
Use of quantitative tools for study planning purposes and study design optimisation Valeria Gigante AIFA - Italian Medicines Agency EMA MSWG 12.06.2016 Public Declaration of transparency/interests* The
More informationProf. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law
Prof. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law SSFFC drugs are medical products that: do not contain any specific active substances, irrespective of the indication
More informationThe Spreading Plague of Counterfeiting
The Spreading Plague of Counterfeiting Harvey Bale Director General International Federation of Pharmaceutical Manufacturers Associations (IFPMA) PSF Assembly Stockholm 25 October 2003 Rising Tide of a
More informationCounterfeit Pharmaceuticals. in Canada. The counterfeit criminal market. in Canada. No country is immune from counterfeit drugs
Criminal Intelligence Service Canada August 2006 Counterfeit Pharmaceuticals in Canada The counterfeit criminal market in Canada Counterfeit goods can be categorized into industry sectors: entertainment
More informationTHE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and
THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and effective. Before any drug is approved for marketing
More informationThe Danish Medicines Agency s availability strategy
låst DECEMBER 2016 The Danish Medicines Agency s availability strategy 2017 2021 Danish Medicines Agency, 2016 This publication may be freely quoted with appropriate acknowledgement of the source. Images
More informationMHRA Anti-counterfeiting Strategy and Supply Chain Guidance
Safeguarding public health MHRA Anti-counterfeiting Strategy and Supply Chain Guidance PQG Annual Meeting for QPs 24 Mar 2010 Nimo Ahmed Head of Intelligence Medicines and Healthcare products Regulatory
More informationHealth Authority Abu Dhabi. Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number:
Health Authority Abu Dhabi Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number: PPR/DMP/DR/P0001 Version 0.9 Approval Date: August 2007 Effective Date: August 2007 Last
More informationFalsified Medicines Directive (FMD) Dispensing Doctors Association Wednesday 18-Oct-17 Jerome Bertin
Falsified Medicines Directive (FMD) Dispensing Doctors Association Wednesday 18-Oct-17 Jerome Bertin Objectives What is FMD all about and when does it need to happen? Who are SecurMed and what is our role
More informationThe fighting in Spain against counterfiting: the Directive and the Delegated Act
The fighting in Spain against counterfiting: the Directive and the Delegated Act Belén Escribano Head of the Pharmaceutical Inspection and Enforcement Department 1 Overview Background Directive implementation
More informationCannabis use carries significant health risks, especially for people who use it frequently and or/begin to use it at an early age.
Background: The Centre for Addiction and Mental Health (CAMH) released recommendations for the Legalization of Marijuana (with restrictions and regulations) on October 8, 2014. Addiction Services of Thames
More informationThe place for treatments of associated neuropsychiatric and other symptoms
The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public
More informationCOMBATING THE ILLICIT TRADE OF CIGARETTE AND TOBACCO PRODUCTS ANTI ILLICIT TRADE CONFERENCE CAPE TOWN, SOUTH AFRICA 9 11 NOVEMBER 2015
COMBATING THE ILLICIT TRADE OF CIGARETTE AND TOBACCO PRODUCTS Colonel John Matroos National Coordinator Head Office Directorate for Priority Crime Investigation South African Police Service matroosjohn@saps.gov.za
More informationDo not open the test booklet prior to being told to do so.
Last Name: Pharmacy 4054 Pharmacy Law Exam II Do not open the test booklet prior to being told to do so. I, the undersigned student, agree to do my best on the exam and that I have only used resources
More informationCannabis Legalization August 22, Ministry of Attorney General Ministry of Finance
Cannabis Legalization August 22, 2018 Ministry of Attorney General Ministry of Finance Federal Cannabis Legalization and Regulation The federal Cannabis Act received Royal Assent on June 21, 2018 and will
More informationRef: E 007. PGEU Response. Consultation on measures for improving the recognition of medical prescriptions issued in another Member State
Ref:11.11.24E 007 PGEU Response Consultation on measures for improving the recognition of medical prescriptions issued in another Member State PGEU The Pharmaceutical Group of the European Union (PGEU)
More informationDSQC Overview. Scott Kuzner, Ph.D. USP Global External Affairs Director
DSQC Overview Scott Kuzner, Ph.D. USP Global External Affairs Director A multi-stakeholder and cross-sector collaborative aimed at improving the quality and safety of products marketed as dietary supplements.
More informationCounterfeit Medicines Toolkit 8. Questions and Answers
Counterfeit Medicines Toolkit 8. Questions and Answers Materials developed in collaboration with: 6/5/2010 Q&A: Definition of Counterfeit Medicine (1) Q: What is the problem with the current definition?
More informationReport. Uganda Pharmaceutical Sector Scan JUNE 2010
Report On the Uganda Pharmaceutical Sector Scan Part of Component 1 of MeTA Baseline Assessments JUNE 2010 Drafted by consultants: 1. Samuel Balyejjusa, B.Pharm., MPH 2. Paschal Mujasi, B.Pharm., MBA 3.
More informationOther EU Activities Contributing to Harmonization of Labeling
Other EU Activities Contributing to Harmonization of Labeling Dr Laurent Brassart European Medicines Agency Medical Information Sector DIA Labeling Harmonisation 2011 Workshop October 13-14. 2011 Disclaimer
More informationMEDICINES PROMOTION AND RATIONAL USE : The Spanish Experience JOSE LUIS DOPICO
MEDICINES PROMOTION AND RATIONAL USE : The Spanish Experience JOSE LUIS DOPICO LEGAL FRAMEWORK General Health Act (1986): Established a National Health System in Spain in accordance with the following
More informationDIRECTIVE 2011/62/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
L 174/74 Official Journal of the European Union 1.7.2011 DIRECTIVE 2011/62/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to
More informationMethamphetamine Human and Environmental Risks
Methamphetamine Human and Environmental Risks Executive Summary Dr. Russ Kennedy Cooperative Extension Service 501-671-2295 rkennedy@uaex.edu Dr. Timothy Killian Human Development and Family Sciences 479-575-7214
More informationPUBLIC CONSULTATION DOCUMENT
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Directorate C Public Health and Risk Assessment POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC PUBLIC CONSULTATION DOCUMENT
More informationEuropean Medicines Enforcement Network
Safeguarding public health European Medicines Enforcement Network 14 th ICDRA, Singapore December 2010 Nimo Ahmed Head of Intelligence Medicines and Healthcare products Regulatory Agency Outline MHRA Enforcement
More informationI. INSTITUTIONAL BUILDING / NATIONAL ANTI-DRUG STRATEGY
I. INSTITUTIONAL BUILDING / NATIONAL ANTI-DRUG STRATEGY Saint Lucia approved its National Anti-Drug and Substance Abuse Strategy (NADSAS), on February 20, 2000, which is valid until February 20, 2005.
More informationCountry specific case studies Best practices to combat counterfeit medicines and to protect public health. Luc Besançon FIP Project Coordinator
Country specific case studies Best practices to combat counterfeit medicines and to protect public health Luc Besançon FIP Project Coordinator Patient safety and pharmaceutical products Internet Counterfeit
More informationUnofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control
Unofficial translation /Ministry of Social Affairs and Health No. 548/2008 Government Decree on Narcotics Control Issued in Helsinki on 28 August 2008 Section 1 Scope of application This Decree lays down
More information14 th International Conference of Drug Regulatory Authorities 30 th November December 2010 Singapore
14 th International Conference of Drug Regulatory Authorities 30 th November 2010 3 December 2010 Singapore CURRENT REGULATORY CHALLENGES RELATING TO HERBAL MEDICINES: ADULTERATION OF HERBAL MEDICINES
More informationEnsuring the gap between science and practice is filled safely - MHRA
Safeguarding public health Ensuring the gap between science and practice is filled safely - MHRA Diane Leakey Head of Information and Communications, MHRA April 2012 Agenda Who is MHRA? Why we have regulation?
More information15638/17 MMA/vdh 1 DGD 1C
Council of the European Union Brussels, 11 December 2017 (OR. en) 15638/17 OUTCOME OF PROCEEDINGS From: General Secretariat of the Council On: 7 December 2017 To: No. prev. doc.: Subject: Delegations 11761/3/17
More informationTable of ConTenTs. 1. The Agencia Española de Medicamentos y Productos Sanitarios, AEMPS: Who we are. 2. How are medicines assessed and authorised?
Table of ConTenTs 1. The Agencia Española de Medicamentos y Productos Sanitarios, AEMPS: Who we are Mission and vision Summary of activity The human team Structure 2 3 4 6 7 2. How are medicines assessed
More informationNovo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology )
Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology ) Table of contents Preamble... 0 1. General Summary... 1 2. Terminology and Definitions... 2 3. Change log... 8 Preamble Novo
More informationREPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD
REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD Ensuring the provision of quality, safe and efficacious pharmaceutical products and services. FUNCTIONS OF THE BOARD BACKGROUND
More informationAct on Narcotic Drugs and Psychotropic Substances and Precursors thereof
Issuer: Riigikogu Type: act In force from: 13.05.2016 In force until: 22.11.2018 Translation published: 06.05.2016 Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof Amended by the
More informationRecommendations 2. Council is asked to note and discuss the findings of the research and how we intend to use it.
COUNCIL Survey of contact lens wearers: research findings Meeting: 10 February 2016 Lead responsibility: Alistair Bridge (Director of Strategy) Status: for noting Project manager/paper author: Marie Bunby
More informationProvider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting
Provider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting Baltimore, MD April 5, 2011 Massachusetts Department of Public Health MA Prescription Monitoring Program
More informationLOGO. Falsification of Medicines. Drug Chemistry and Technology Basics, Cleaner Production and Mega-Trends in Pharmaceutical Industry
LOGO Drug Chemistry and Technology Basics, Cleaner Production and Mega-Trends in Pharmaceutical Industry Falsification of Medicines Dr. As. Prof. Anastasiya Sladkova Dr. Sci. Prof. Natalya Loginova 1 Questions
More informationSummary of product characteristics (SmPC)
Summary of product characteristics (SmPC) What is it and what does it contain? An agency of the European Union Table of contents 1.What is the summary of product characteristics (SmPC)? 2.Where SmPC information
More informationORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies
ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies ISSUING BODY: The Ministry of Health published in: the Official
More informationCOUNTERFEIT DRUGS IN INDIA
COUNTERFEIT DRUGS IN INDIA a part presentation from the on-going dissertation Global Threat of Counterfeit Drugs A Study Covering Extent of Problem and Anticounterfeit Measures in Europe & India By, Viraj
More informationAGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)
AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred
More informationCDER Compliance Update
CDER Compliance Update Douglas Stearn, JD Deputy Director for Policy and Analysis FDA/CDER/Office of Compliance FDLI Enforcement, Litigation and Compliance Conference Washington, DC December 12, 2012 1
More informationCannabis Legalization in Alberta
Cannabis Legalization in Alberta Regulation and Supply Chain Roundtable #3 Discussion Topics Potential for cannabis cafes or lounges Public education priorities Potential for economic development Alberta
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-EIGHTH REGULAR SESSION November 11-13, 2015 Trujillo, Perú OEA/Ser.L/XIV.2.58 CICAD/doc.2207/15 6
More informationDrug Administration Law of the People's Republic of China Order of the President of the Peoples Republic of China. (No. 45)
Drug Administration Law of the People's Republic of China Order of the President of the Peoples Republic of China (No. 45) The Drug Administration Law of the People s Republic of China, revised at the
More informationBILATERAL SCREENING MEETING
Negotiating Group for the Accession of the Republic of Serbia to the European Union - Chapter 28, Consumer and Health Protection BILATERAL SCREENING MEETING Chapter 28 Consumer and Health Protection Brussels,
More informationLAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY
LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY President s Office No. 13/PO DECREE of the PRESIDENT of the LAO PEOPLE S DEMOCRATIC REPUBLIC On the Promulgation of the Law
More informationMedical Devices. BARBADOS Clarke Gittens Farmer
Medical Devices BARBADOS Clarke Gittens Farmer CONTACT INFORMATION Danielle Maycock Clarke Gittens Farmer Parker House, Wildey Business Park Wildey Road, St. Michael, Barbados Tel. 246.436.6287 rsm@clarkes.com.bb
More informationPOSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC PUBLIC CONSULTATION DOCUMENT
POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC DG SANCO 2010 PUBLIC CONSULTATION DOCUMENT Answer given by the General Direction of Public Health of the Spanish Ministry of Health and Social
More informationSecond China-EU Symposium on Gender Equality under HPPD
Boosting Employment and Entrepreneurship of Young Women Shanghai, 14 November 2017 Ms Annelies Pierrot Bults, Executive Member of the European Women s Lobby Madam President of the All China Women s Federation,
More informationArchived Content. Contenu archivé
ARCHIVED - Archiving Content ARCHIVÉE - Contenu archivé Archived Content Contenu archivé Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject
More informationChanging practice to support service delivery
Nurse and Midwife Medicinal Product Prescribing Toolkit Authorised Medicinal Products, Off-label Prescription and Exempt Medicinal Products Toolkit Changing practice to support service delivery Introduction
More informationGuideline for the Rational Use of Controlled Drugs
Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import
More informationFrequently asked questions
13 February 2017 EMA/527628/2011 Rev. 1 Directorate This document provides answers to the most frequently asked questions received by the European Medicines Agency (EMA).If the answer to your question
More informationB.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations
B.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations Copyright February 2018, Province of British Columbia. All rights reserved. This material is owned by the Government of British
More information6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES
CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE John Karwoski, RPh, MBA DISCLOSURE I, John Karwoski, RPH, MBA have business relationships with the companies MOBIUS THERAPEUTICS, LLC, Cubex, and
More informationResponsible Retailing of Recreational Cannabis. Recommendations to British Columbia s Cannabis Regulation Engagement Secretariat
Responsible Retailing of Recreational Cannabis Recommendations to British Columbia s Cannabis Regulation Engagement Secretariat Introduction On behalf of British Columbia s Alliance of Beverage Licensees
More informationStrategies to Prevent Pharmaceutical Waste: Modifying Co-Pay Structures
Modifying Co-Pay Structures Extended producer responsibility (EPR) is a policy approach in which the producer s responsibility for their product extends to the post-consumer management of that product
More informationLegal and fiscal asymmetries in Europe, their impact on the illicit tobacco markets and the counteracting action
Tobacco Road Roma, 19 Gennaio 2018 Legal and fiscal asymmetries in Europe, their impact on the illicit tobacco markets and the counteracting action Ernesto U. Savona Director and Professor ernesto.savona@unicatt.it
More informationLAW ON MINERAL FERTILIZERS. Official Gazette of Bosnia and Herzegovina, 46/04
LAW ON MINERAL FERTILIZERS Official Gazette of Bosnia and Herzegovina, 46/04 Pursuant to Article IV.4.a) of the Constitution of Bosnia and Herzegovina, the Parliamentary Assembly of Bosnia and Herzegovina,
More information14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region
14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region Budiono Santoso Team Leader Essential Medicines & Technologies, World Health Organization,
More informationCannabis Retail Regulation and Licence Applications PART 1 NOVEMBER 27, 2018
Cannabis Retail Regulation and Licence Applications PART 1 NOVEMBER 27, 2018 Speakers from the AGCO Phil Serruya (Panel Moderator) Director, Communications Tom Mungham Chief Operating Officer Brent McCurdy
More informationInformal meeting of the Justice and Home Affairs Ministers Sopot July 2011
Informal meeting of the Justice and Home Affairs Ministers Sopot 18-19 July 2011 New challenges to EU anti-drug policy. I. Introduction Every hour an EU citizen dies of a drug overdose. There are as many
More informationQuality, Safety and Sourcing in Unlicensed Medicines
Quality, Safety and Sourcing in Unlicensed Medicines with Andrew Trouton Managing Director, UL Medicines Agenda Welcome What is an unlicensed medicine? When should you consider using an unlicensed medicine?
More informationOPPORTUNITIES FOR OMEGA-3 PRODUCTS
OPPORTUNITIES FOR OMEGA-3 PRODUCTS Prepared by: CPL Business Consultants The Manor House, Howbery Park, Wallingford, Oxfordshire, OX10 8BA Tel: +44 1491 822 844, info@cplconsult.com, www.cplconsult.com
More informationCounterfeit Medicinal Products. SPAIN Uría Menéndez
Counterfeit Medicinal Products SPAIN Uría Menéndez CONTACT INFORMATION Beatriz Cocina Uría Menéndez Príncipe de Vergara, 187 Plaza de Rodrigo Uría 28002 Madrid Spain 34.91.586.04.46 beatriz.cocina@uria.com
More informationPhilippine Strategy for the. Free Alternatives. under the National CFC Phase-out Plan (NCPP)
Philippine Strategy for the Transition from CFCcontaining MDIs to CFC- Free Alternatives under the National CFC Phase-out Plan (NCPP) 1 Developing the Transition Strategy Findings of the study of the MDIs
More informationEconomic Impact of Counterfeiting
Economic Impact of Counterfeiting Why current practice makes it so difficult to assess economic impact and steps toward a solution Alexander A Theil, M.A. Transatlantic IP Collaboration Conference April
More informationGlobal Pediatric Development: We Are Making Progress. PMDA Perspective. Junko Sato, PhD PMDA
Global Pediatric Development: We Are Making Progress PMDA Perspective Junko Sato, PhD PMDA Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter
More informationImporting pre-packaged foods
Importing pre-packaged foods Information for those who wish to import pre-packa Starting your business This brochure provides important information for those who wish to import and sell pre-packaged foods
More informationACTION PLAN. Intergovernmental Coordinating Body, Ministry of Finance. Intergovernmental Coordinating Body, Ministry of Finance
ACTION PLAN Strategic goal 1: Reduction of tobacco demand which should reduce the prevalence of smoking in the population Objectives Activity/Action Responsible Party/Implementing Body Deadline Source
More informationSACI ALCOHOL AND DRUG ABUSE PREVENTION POLICY
SACI ALCOHOL AND DRUG ABUSE PREVENTION POLICY Alcohol and Drugs The information in this section of the web site on drug and alcohol use is provided in response to the Drug-Free Schools and Communities
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 23.11.2009 SEC(2009) 1621 final COMMISSION STAFF WORKING DOCUMENT Report on the implementation of the Council Recommendation of 2 December 2002 on the prevention
More informationFood Safety Regulation Chapter One Definitions
Food Safety Regulation Chapter One Definitions Article (1): In the application of the provisions of these regulations, words and terms herein shall have the meanings stated in Food Safety Law. The following
More informationCooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia s experience so far
Cooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia s experience so far Ana Boban, MPharm. Agency for Medicinal Product and Medical Devices of Croatia Dubrovnik, 06.05.2013.
More informationBarbara Brohl Executive Director & State Licensing Authority Colorado Department of Revenue
Barbara Brohl Executive Director & State Licensing Authority Colorado Department of Revenue 1 Background and History Colorado Industry Segments Legislative Process Rulemaking Process Regulatory & Enforcement
More informationRESOLUTION OF THE STATE GREAT KHURAL OF MONGOLIA. 11 October 2002 No: 68 Ulaanbaatar. Adoption of the Government Policy on Drugs
Translation from Mongolian RESOLUTION OF THE STATE GREAT KHURAL OF MONGOLIA 11 October 2002 No: 68 Ulaanbaatar Adoption of the Government Policy on Drugs The State Great Khural of Mongolia RESOLVES: 1.
More informationAttitudes, Awareness and Understanding
TMA Smokers Anti-Illicit Trade Survey 2018: Attitudes, Awareness and Understanding In April and May 2018, the TMA commissioned a nationwide poll of adult smokers to understand their attitudes, awareness
More informationEMEA PANDEMIC INFLUENZA CRISIS MANAGEMENT PLAN FOR THE EVALUATION AND MAINTENANCE OF PANDEMIC INFLUENZA VACCINES AND ANTIVIRALS
European Medicines Agency London, 21 August 2006 Doc. Ref. EMEA/214301/2006 EMEA PANDEMIC INFLUENZA CRISIS MANAGEMENT PLAN FOR THE EVALUATION AND MAINTENANCE OF PANDEMIC INFLUENZA VACCINES AND ANTIVIRALS
More informationOrganization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.
Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Saint Lucia 2009 EVALUATION OF PROGRESS IN DRUG CONTROL IMPLEMENTATION OF RECOMMENDATIONS
More informationPolicy Options for the Regulation of Electronic Cigarettes
Policy Options for the Regulation of Electronic Cigarettes Consultation submission This submission was completed by: (name) Position (if applicable): Evon Currie General Manager, Community and Public Health
More informationRe: Items and Cannabis Legalization
Re: Items 14.1.9 and 14.1.10 Cannabis Legalization HRM Council June 19, 2018 What we ve learned so far Think about your regulatory structure sooner rather than later! Learn from others and anticipate the
More informationVaccine shortages: Improving cooperation, communication and management Michael Sulzner
Vaccine shortages: Improving cooperation, communication and management Michael Sulzner Public Health Directorate DG Health & Food Safety 13 April 2016, Geneva Decision 1082/2013/EU on serious cross-border
More informationCardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention
Cardinal Health s Commitment to Opioid Anti-Diversion, Education and Misuse Prevention The people of Cardinal Health care deeply about the devastation opioid abuse has caused American families and communities
More informationOrganization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.
Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD Multilateral Evaluation Mechanism MEM Paraguay 2005 PROGRESS REPORT IN DRUG CONTROL IMPLEMENTATION OF RECOMMENDATIONS
More informationCABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND
CABINET Report No: 105/2017 PUBLIC REPORT 16 May 2017 PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND Report of the Director of Public Health Strategic Aim: Safeguarding Key Decision:
More informationEuropean Food Safety Authority
AF 01.10.2004 3a Discussion paper on Botanicals European Food Safety Authority SCIENTIFIC COMMITTEE Brussels, 25 June 2004 EFSA/SC/26 Final Discussion Paper on Botanicals and Botanical Preparations widely
More informationIntellectual Property Rights Fiscal Year 2012 Seizure Statistics. Prepared by U.S. Customs and Border Protection Office of International Trade
Intellectual Property Rights Fiscal Year 2012 Seizure Statistics Prepared by U.S. Customs and Border Protection Office of International Trade Intellectual Property Rights Fiscal Year 2012 Seizure Statistics
More informationLEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018
LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018 DISCLAIMER The material presented is general legal information and is not legal advice. Specific
More informationBIIAB LEVEL 1 AWARD IN RESPONSIBLE ALCOHOL RETAILING. Specimen Examination Paper
BIIAB LEVEL 1 AWARD IN RESPONSIBLE ALCOHOL RETAILING Specimen Examination Paper The specimen examination questions contained in this publication are representative of the type of questions used to assess
More informationMEMORANDUM INTRODUCTION. DATE: July 28, 2016; Revised August 3, 2016 TO:
MEMORANDUM DATE: July 28, 2016; Revised August 3, 2016 TO: Lehigh Valley Planning Commission FROM: Becky Bradley, AICP, Executive Director CC: Staff REGARDING: Land Use Implications of the Medical Marijuana
More information